Results 1 to 10 of about 14,049,459 (229)

The Problems with Systematic Reviews: A Living Systematic Review.

open access: yesJournal of Clinical Epidemiology, 2023
OBJECTIVE Systematic reviews and meta-analyses are proliferating, as they are an important building block to inform evidence-based guidelines and decision-making.
L. Uttley   +7 more
semanticscholar   +4 more sources

The PRISMA 2020 statement: An updated guideline for reporting systematic reviews

open access: yesPLoS Medicine, 2021
Matthew Page and co-authors describe PRISMA 2020, an updated reporting guideline for systematic reviews and meta-analyses.
M. Page   +25 more
semanticscholar   +3 more sources

PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews

open access: yesSystematic Reviews, 2021
Background Literature searches underlie the foundations of systematic reviews and related review types. Yet, the literature searching component of systematic reviews and related review types is often poorly reported.
M. Rethlefsen   +40 more
semanticscholar   +2 more sources

PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews

open access: yesBritish medical journal, 2020
The methods and results of systematic reviews should be reported in sufficient detail to allow users to assess the trustworthiness and applicability of the review findings.
M. Page   +25 more
semanticscholar   +1 more source

High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation

open access: yesHealth Technology Assessment, 2021
Background: Early diagnosis of acute myocardial infarction is important, but only 20% of emergency admissions for chest pain will actually have an acute myocardial infarction.
Marie Westwood   +9 more
doaj   +1 more source

A systematic review of clinical effectiveness and safety for historical and current treatment options for metachromatic leukodystrophy in children, including atidarsagene autotemcel

open access: yesOrphanet Journal of Rare Diseases, 2023
Objective To understand the benefit-risk profile for historical and current treatments for MLD. Methods A systematic review was conducted on the effectiveness, safety, and costs of MLD treatments: allogeneic haematopoietic stem cell transplantation (HSCT)
Nigel Armstrong   +3 more
doaj   +1 more source

A focus on cross-purpose tools, automated recognition of study design in multiple disciplines, and evaluation of automation tools: a summary of significant discussions at the fourth meeting of the International Collaboration for Automation of Systematic Reviews (ICASR) [PDF]

open access: yes, 2020
The fourth meeting of the International Collaboration for Automation of Systematic Reviews (ICASR) was held 5–6 November 2019 in The Hague, the Netherlands.
Glasziou, Paul   +5 more
core   +3 more sources

Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline

open access: yesBritish medical journal, 2020
In systematic reviews that lack data amenable to meta-analysis, alternative synthesis methods are commonly used, but these methods are rarely reported. This lack of transparency in the methods can cast doubt on the validity of the review findings.
M. Campbell   +11 more
semanticscholar   +1 more source

Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis

open access: yesHealth Technology Assessment, 2020
Background: There have been no licensed treatment options in the UK for treating thrombocytopenia in people with chronic liver disease requiring surgery.
Nigel Armstrong   +15 more
doaj   +1 more source

Efficacy of antimalarial herbal medicines used by communities in malaria affected regions globally: a protocol for systematic review and evidence and gap map

open access: yesBMJ Open, 2023
Introduction With the rising resistance to artemisinin-based combination treatments, there is a need to hasten the discovery and development of newer antimalarial agents. Herbal medicines are key for the development of novel drugs.
Nakalembe Loyce   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy